SINOPHARM GROUP 1/5/O.N. (X2S1) — Defensive Interval Ratio
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Defensive Interval Ratio of 288 days as of December 2025. Defensive assets of €194.61 Billion (cash €-, short-term investments €129.00K, receivables €194.61 Billion) cover 288 days of daily cash needs of €675.96 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SINOPHARM GROUP 1/5/O.N. Defensive Interval Ratio (2021–2025)
This chart shows how SINOPHARM GROUP 1/5/O.N.'s Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 288 days, meaning defensive assets of €194.61 Billion can fund 288 days of operations without new revenue. For the complete balance sheet picture, see X2S1 total asset value.
Annual Defensive Interval Ratio for SINOPHARM GROUP 1/5/O.N. (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is SINOPHARM GROUP 1/5/O.N.'s working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 288 days | €194.61 Billion | €675.96 Million/day | €- | €129.00K | ▲ +14 days |
| 2024 | 274 days | €187.64 Billion | €685.96 Million/day | €- | €158.00K | ▲ +18 days |
| 2023 | 255 days | €169.00 Billion | €661.62 Million/day | €- | €547.00K | ▲ +14 days |
| 2022 | 242 days | €155.58 Billion | €643.73 Million/day | €- | €498.00K | ▼ -27 days |
| 2021 | 269 days | €161.41 Billion | €600.84 Million/day | €- | €11.75 Million | — |